Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-041070
Filing Date
2016-11-04
Accepted
2016-11-04 07:13:33
Documents
62
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbm20160817_10q.htm 10-Q 910810
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 16002
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 15474
4 EXHIBIT 32 ex32.htm EX-32 8406
  Complete submission text file 0001437749-16-041070.txt   4738174

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS cbm-20160930.xml EX-101.INS 1002108
6 EXHIBIT 101.SCH cbm-20160930.xsd EX-101.SCH 44735
7 EXHIBIT 101.CAL cbm-20160930_cal.xml EX-101.CAL 50667
8 EXHIBIT 101.DEF cbm-20160930_def.xml EX-101.DEF 318283
9 EXHIBIT 101.LAB cbm-20160930_lab.xml EX-101.LAB 287784
10 EXHIBIT 101.PRE cbm-20160930_pre.xml EX-101.PRE 346292
Mailing Address ONE MEADOWLANDS PLAZA E. RUTHERFORD NJ 07073
Business Address ONE MEADOWLANDS PLZ E RUTHERFORD NJ 07073 2018043000
CAMBREX CORP (Filer) CIK: 0000820081 (see all company filings)

EIN.: 222476135 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10638 | Film No.: 161973608
SIC: 2834 Pharmaceutical Preparations